Tilray Stock
Tilray provides pharmaceutical-grade cannabis products to patients, researchers, pharmacies, and governments.
Sign up today and learn more about Tilray Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Tilray Stock
Tilray provides pharmaceutical-grade cannabis products to patients, researchers, pharmacies and governments. Tilray cultivates and delivers the benefits of medical cannabis safely and reliably. Healthcare practitioners and patients expect and deserve only the best service and products. Accordingly, Tilray provides expedited delivery, prompt follow-up, and consistent quality of each strain they harvest.
Funding History
| February 2018 | $60.0M |
|---|
Management
Director
Catherine Jacobson
Founder
Brendan Kennedy
Co-Founder
Christian Groh
Press
Seeking Alpha - Jun, 27 2018
Tilray Seeks $100 Million IPO In US FilingInternational Financing Review - Jun, 25 2018
Canada: Tilray files for US floatPitchBook News & Analysis - Jun, 22 2018
Canadian cannabis company cultivates IPOAxios - Jun, 21 2018
Tilray files for IPO, after Canada legalizes marijuanaBusiness Wire (press release) - Apr, 4 2018
Tilray® Launches High Park Company™ to Produce and Distribute Adult-Use Cannabis in CanadaBusiness Wire (press release) - Mar, 19 2018
Tilray® Forms Strategic Alliance with Leading Pharmaceutical Company in CanadaEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
